Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients

Objective. High mobility group box 1 (HMGB1) is a late inflammatory factor participating in the pathogenesis of various autoimmune and inflammatory diseases. In the current study, we analyzed the association between serum levels of HMGB1 and clinical features of AS patients before and during treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chenqiong, Miao, Ye, Wu, Xuefen, Huang, Yishu, Sun, Mengchen, Zhu, Yingzi, Zheng, Fang, Sun, Wei, Dong, Lingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069358/
https://www.ncbi.nlm.nih.gov/pubmed/27800496
http://dx.doi.org/10.1155/2016/6537248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069358/
https://www.ncbi.nlm.nih.gov/pubmed/27800496
http://dx.doi.org/10.1155/2016/6537248

Ejemplares similares